Indonesia Malaysia Vietnam Thailand Philippines Australia New Zealand China Korea And India Veterinary Medicine Market
Tamaño del mercado en miles de millones de dólares
Tasa de crecimiento anual compuesta (CAGR) :
% 
 Período de pronóstico |
2023 –2030 |
 Tamaño del mercado (año base) |
|
 Tamaño del mercado (año de pronóstico) |
USD 6,811.52 |
 Tasa de crecimiento anual compuesta (CAGR) |
% |
| Jugadoras de los principales mercados |
Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market, By Product (Vaccines, Medication, and Supplements), Animal Type (Food Production and Companion Animals), Dosage (Solid, Liquid, and Semi-Solid), Route of Administration (Oral, Parenteral, and Topical), Application (Foot and Mouth Disease, Autoimmune Diseases, Bacterial Diseases, Helminthes Infection, Bluetongue, Canine Atopic Dermatitis, and Others), End User (Hospitals, Veterinary Clinics, Homecare Settings, and Laboratories), Distribution Channel (Direct Tender, Retail Sales, Online Pharmacy, and Others) - Industry Trends and Forecast to 2030.
Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market Analysis and Size
Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India veterinary medicine market is fragmented in nature, as it consists of many global players such as Zoetis Services LLC, Boehringer Ingelheim International GmbH., Virbac, Ceva, and Dechra Pharmaceuticals PLC. among others. The presence of these companies produces competitive prices for veterinary medicines across the region. Due to the presence of these players at regional and international levels, suppliers and manufacturers offer products with different specifications and characteristics in all budgets. The rising pet ownership and humanization of pets are driving the market growth. Additionally, the rising prevalence of animal diseases is expected to drive the market growth.
Data Bridge Market Research analyzes that, Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India veterinary medicine market is expected to reach a value of USD 6,811.52 million by 2030, at a CAGR of 10.1% during the forecast period. This market report also covers pricing analysis and technological advancements in depth.
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015 - 2020) |
|
Quantitative Units |
Revenue in Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Product (Vaccines, Medication, and Supplements), Animal Type (Food Production and Companion Animals), Dosage (Solid, Liquid, and Semi-Solid), Route of Administration (Oral, Parenteral, and Topical), Application (Foot and Mouth Disease, Autoimmune Diseases, Bacterial Diseases, Helminthes Infection, Bluetongue, Canine Atopic Dermatitis, and Others), End User (Hospitals, Veterinary Clinics, Homecare Settings, and Laboratories), Distribution Channel (Direct Tender, Retail Sales, Online Pharmacy, and Others) |
|
Countries Covered |
India, Australia, China, Indonesia, Malaysia, New Zealand, Korea, Vietnam, Thailand, and Philippines |
|
Market Players Covered |
Zoetis Services LLC (U.S.), Boehringer Ingelheim International GmbH.(Germany), Virbac (France), Ceva (France), Dechra Pharmaceuticals PLC (England), HUVEPHARMA (Bulgaria), Phibro Animal Health Corporation (U.S.), Kemin Industries, Inc.(U.S.), Vetoquinol (France), Mankind Pharma (India), Indian Immunologicals Ltd.(India), ECO Animal Health Ltd (U.K.), Biologische Heilmittel Heel GmbH, Alivira Animal Health Limited, Jurox Pty Limited, Biogénesis Bagó (Germany), Bentoli (U.S.), Inovet (Hungary), MSD Animal Health (U.S.), Zovix Pharmaceuticals (India), and Valor Chemical Co., Ltd (China) among others |
Market Definition
The veterinary medicines market refers to the industry that develops, produces, and sells medicines and other healthcare products for animals. This includes medicines for pets, livestock, and other animals. The market is driven by the increasing demand for animal healthcare services and products, and the growing awareness of the importance of animal health and welfare. The veterinary medicines market includes various products such as vaccines, antibiotics, parasiticides, and anti-inflammatory drugs. The market is also influenced by factors such as government regulations, advancements in technology, and the level of competition.
Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
DRIVERS
Increasing Pet Ownership and Humanization of Pets
The experience of pet ownership exists across many cultures in the world. In many countries, such as India, China, Korea, Thailand, Vietnam, and Australia a majority of people live with pets. Pet ownership is increasing due to a combination of factors such as the desire for companionship, health benefits, changing attitudes towards pets, and increased disposable income. Pets provide companionship and emotional support, which is especially important for people who live alone or have limited social interactions. Studies have shown that pet ownership can have numerous health benefits, including lower blood pressure, reduced stress levels, and improved mental health. Thus, more people move to urban areas, they may feel isolated and disconnected from nature. Owning a pet can provide a sense of connection to the natural world and a source of comfort.
Again as disposable income increases, people may have more money to spend on pets and pet-related expenses such as food, toys, and healthcare. Attitudes towards pets have changed over time, with many people now viewing pets as members of the family rather than just animals. The rise of social media has also contributed to the popularity of pet ownership, with many people sharing photos and stories of their pets online and connecting with other pet owners. Similarly, the humanization of pets refers to the trend of treating pets as members of the family and providing them with the same level of care and attention as human family members. This includes providing high-quality food, healthcare, and grooming services, and treating pets as companions and sources of emotional support.
Thus, more people adopt pets, the overall demand for veterinary medicines increases to meet the needs of these pets. Pet owners are increasingly interested in preventive healthcare for their pets, which involves regular check-ups and vaccinations. This leads to an increased demand for veterinary medicines such as vaccines and flea and tick preventives. Overall, pet adoption leads to an increased demand for veterinary medicines as pet owners seek to provide their pets with the best possible care and treatment. This trend is expected to continue as pet ownership continues to grow and pet owners become more invested in their pets' health and well-being.
Growing Prevalence of Animal Diseases
Growing animal diseases are related to increasing veterinary medicines because as the number of animal diseases increases, the demand for effective treatments and preventative measures also increases. This leads to the development and production of more veterinary medicines to address the various diseases and conditions affecting animals.
The use of veterinary medicines is essential in managing and controlling animal diseases, and their effectiveness can help reduce the spread of diseases and improve animal health. Therefore, the increasing need for veterinary medicines is directly related to the growing number of animal diseases and the need for effective interventions to manage them.
For instance,
- In December 2022, as per NCBI, Malaysia experienced an outbreak of Highly Pathogenic Avian Influenza (HPAI) 2021, which is a viral disease affecting birds. The outbreak resulted in the culling of thousands of birds, leading to a significant loss in the country's poultry industry
- In September 2021, an article published in Springer Nature that in 2019, China experienced an outbreak of African Swine Fever (ASF), which is a highly contagious disease affecting pigs. The outbreak resulted in the culling of millions of pigs, leading to a significant loss in the country's pork industry
According to above instances, it can be concluded that the growing prevalence of animal diseases is driving the growth of Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India veterinary medicine market in the forecast period.
OPPORTUNITY
Development of Novel and Personalized Veterinary Medicines
The development of novel and personalized veterinary medicines presents a significant opportunity for the veterinary medicines market. Personalized veterinary medicine refers to the use of targeted therapies based on a specific animal's genetic makeup, medical history, and other factors. This approach allows for more precise and effective treatment, with fewer side effects. The development of personalized veterinary medicines is closely related to advances in genomics and other areas of biomedical research. These advances have enabled researchers to better understand the underlying causes of diseases in animals and to develop targeted therapies that address these causes. Furthermore, there is a growing demand for personalized veterinary medicines among pet owners and veterinarians.
This demand is driving innovation in the veterinary medicines market, with new products and therapies being developed to address a wide range of conditions. In addition, the development of personalized veterinary medicines is also driving growth in the animal diagnostics market. As more animals are diagnosed with specific diseases or conditions, there is an increasing need for diagnostic tests that can accurately identify these conditions. Overall, the development of novel and personalized veterinary medicines is creating significant opportunities for growth in the veterinary medicines market. As research and development continue to advance, we can expect to see continued innovation and growth in this important sector.
RESTRAINT / CHALLENGE
High Cost of Veterinary Medicines
High prices of veterinary medicines may limit the affordability of pet owners and farmers, leading to reduced demand for these medicines. This could result in lower revenues for veterinary medicine manufacturers and distributors. When pet owners or farmers cannot afford the high cost of veterinary medicines, they may not comply with the recommended treatment regimen. This could result in poor health outcomes for animals and reduced effectiveness of the medicine.
High prices of veterinary medicines may attract new entrants to the market who offer lower-priced alternatives. This could increase competition and reduce market share for existing manufacturers. High prices of veterinary medicines may attract regulatory scrutiny and lead to increased regulation of the market. This could increase costs for manufacturers and distributors, leading to higher prices for consumers. Overall, the high cost of veterinary medicines can limit the growth of the market by reducing demand, increasing competition, and attracting regulatory attention.
Post-COVID-19 Impact on the Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market
COVID-19 created a negative impact on the Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India veterinary medicine market. The lockdown restriction led to the emergence of various challenges such as decreased transportation and communication facilities as well as decreased veterinary hospital visits, thereby delaying the treatment procedures.
The COVID-19 pandemic has impacted the market to an extent in negative manner. However, increasing government support and advancements in veterinary medicines and technology is expected to provide lucrative opportunities for market growth. Moreover, increasing partnerships, acquisitions, and collaboration among market players are expected to further fuel the market growth. Also, the growth was high since the market opened after COVID-19, and it is expected that there would be considerable growth in the sector. The market players are conducting multiple activities to improve veterinary medicines. With this, the companies will bring advancement and innovation to the market.
Recent Developments
- In April 2023, MSD Animal Health received marketing authorization from European Commission for BOVILIS Nasalgen-C live vaccine for cattle. This has helped the company to establish its global presence in the market.
- In September 2022, Zoetis Services LLC announced that it has completed the acquisition of Jurox, a privately held animal health company that develops, manufactures, and markets a wide range of veterinary medicines for treating livestock and companion animals.
Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market Scope
Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India veterinary medicine market is segmented into seven notable segments based on product, animal type, dosage, route of administration, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Vaccines
- Medication
- Supplements
Based on product, the market is segmented into vaccines, medication, and supplements.
Animal Type
- Food Production
- Companion Animals
Based on animal type, the market is segmented into food production and companion animals.
Dosage
- Solid
- Liquid
- Semi-Solid
Based on dosage, the market is segmented into solid, liquid, and semi-solid.
Route of Administration
- Oral
- Parenteral
- Topical
Based on route of administration, the market is segmented into oral, parenteral, and topical.
Application
- Foot and Mouth Disease
- Autoimmune Diseases
- Bacterial Diseases
- Helminthes Infection
- Bluetongue
- Canine Atopic Dermatitis
- Others
Based on application, the market is segmented into foot and mouth disease, autoimmune diseases, bacterial diseases, helminthes infection, bluetongue, canine atopic dermatitis, and others.
End User
- Hospitals
- Veterinary Clinics
- Homecare Settings
- Laboratories
Based on end user, the market is segmented into hospitals, veterinary clinics, homecare settings, and laboratories.
Distribution Channel
- Direct Tender
- Retail Sales
- Online Pharmacy
- Others
Based on distribution channel, the market is segmented into direct tender, retail sales, online pharmacy, and others.
Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market Analysis/Insights
The Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India veterinary medicine market is analyzed and market size insights and trends are provided by country, product, animal type, dosage, route of administration, application, end user and distribution channel as referenced above. The countries covered in this market report are India, Australia, China, Indonesia, Malaysia, New Zealand, Korea, Vietnam, Thailand, and Philippines. India is dominating the market with the largest market share. This share is attributable to the presence of key market players such as Zoetis Services LLC, Boehringer Ingelheim International GmbH., Virbac, Ceva, and Dechra Pharmaceuticals PLC. among others. Rising pet ownership and humanization of pets are anticipated to fuel the market growth during the forecast period in this region.
The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends, Porter’s five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India Veterinary Medicine Market Share Analysis
The Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India veterinary medicine market competitive landscape provides details of the competitor. Details included are company overview, company financials, revenue generated, market potential, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major market players operating in the Indonesia, Malaysia, Vietnam, Thailand, Philippines, Australia, New Zealand, China, Korea, and India veterinary medicine market are Zoetis Services LLC (U.S.), Boehringer Ingelheim International GmbH.(Germany), Virbac (France), Ceva (France), Dechra Pharmaceuticals PLC (England), HUVEPHARMA (Bulgaria), Phibro Animal Health Corporation (U.S.), Kemin Industries, Inc.(U.S.), Vetoquinol (France), Mankind Pharma (India), Indian Immunologicals Ltd.(India), ECO Animal Health Ltd (U.K.), Biologische Heilmittel Heel GmbH, Alivira Animal Health Limited, Jurox Pty Limited, Biogénesis Bagó (Germany), Bentoli (U.S.), Inovet (Hungary), MSD Animal Health (U.S.), Zovix Pharmaceuticals (India), and Valor Chemical Co., Ltd (China) among others.
SKU-
Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo
- Panel de análisis de datos interactivo
- Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
- Acceso de analista de investigación para personalización y consultas
- Análisis de la competencia con panel interactivo
- Últimas noticias, actualizaciones y análisis de tendencias
- Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Tabla de contenido
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 CURRENCY AND PRICING
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT SEGMENT LIFELINE CURVE
2.8 MARKET END USER COVERAGE GRID
2.9 DBMR MARKET POSITION GRID
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES MODEL
5 INDUSTRY INSIGHTS
5.1 PATENT ANALYSIS
5.2 DRUG TREATMENT RATE BY MATURED MARKETS
5.3 DEMOGRAPHIC TRENDS: IMPACTS ON ALL INCIDENCE RATES
5.4 PATIENT FLOW DIAGRAM
5.5 KEY PRICING STRATEGIES
5.6 KEY PATIENT ENROLLMENT STRATEGIES
6 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: REGULATIONS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING PET OWNERSHIP AND HUMANIZATION OF PETS
7.1.2 GROWING PREVALENCE OF ANIMAL DISEASES
7.1.3 ADVANCEMENTS IN VETERINARY MEDICINE AND TECHNOLOGY
7.1.4 INCREASING GOVERNMENT INITIATIVES FOR ANIMAL HEALTH AND WELFARE
7.2 RESTRAINTS
7.2.1 HIGH COST OF VETERINARY MEDICINES
7.2.2 STRINGENT REGULATORY REQUIREMENTS FOR APPROVAL
7.3 OPPORTUNITIES
7.3.1 DEVELOPMENT OF NOVEL AND PERSONALIZED VETERINARY MEDICINES
7.3.2 INCREASING TREND TOWARDS PREVENTIVE HEALTHCARE FOR ANIMALS
7.3.3 RISING DEMAND FOR NATURAL AND HERBAL VETERINARY MEDICINES
7.4 CHALLENGES
7.4.1 LIMITED R&D FUNDING FOR VETERINARY MEDICINES
7.4.2 LACK OF SKILLED VETERINARY PROFESSIONALS
8 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, & INDIA VETERINARY MEDICINE MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 VACCINES
8.2.1 LIVE ATTENUATED VACCINES
8.2.2 TOXOID VACCINES
8.2.3 RECOMBINANT VACCINES
8.2.4 INACTIVATED VACCINES
8.2.5 OTHERS
8.3 MEDICATION
8.3.1 ANTIBIOTICS
8.3.1.1 AMOXICILLIN
8.3.1.2 AMPICILLIN
8.3.1.3 LINCOMYCIN
8.3.1.4 COLISTIN
8.3.1.5 GENTAMICIN
8.3.1.6 TETRACYCLINE
8.3.1.7 DOXYCYCLINE
8.3.1.8 TYLOSIN
8.3.1.9 OTHERS
8.3.2 ANALGESICS
8.3.2.1 ANTI-INFLAMMATORY (NSAIDS)
8.3.2.2 ACETAMINOPHEN
8.3.2.3 FIROCOXIB
8.3.2.4 MELOXICAM
8.3.2.5 CARPROFEN
8.3.2.6 DERACOXIB
8.3.2.7 PHENYLBUTAZONE
8.3.2.8 OTHERS
8.3.2.9 OPIOIDS
8.3.2.10 MU AGONISTS
8.3.2.10.1 MORPHINE
8.3.2.10.2 OXYMORPHONE
8.3.2.10.3 METHADONE
8.3.2.10.4 MEPERIDINE
8.3.2.10.5 OTHERS
8.3.2.11 KAPPA AGONIST-MU ANTAGONIST
8.3.2.11.1 BUTORPHANOL
8.3.2.11.2 OTHERS
8.3.2.12 PARTIAL MU AGONIST
8.3.2.13 BUPRENORPHINE
8.3.2.14 OTHERS
8.3.3 PARASITICIDES
8.3.3.1 AMPROLIUM
8.3.3.2 BENZIMIDAZOLES
8.3.3.3 NITROIMIDAZOLES
8.3.3.4 ALBENDAZOLE
8.3.3.5 PIPERAZINE
8.3.3.6 DELTAMETHRIN
8.3.3.7 LEVAMISOLE
8.3.3.8 OTHERS
8.3.4 ANTIHISTAMINES
8.3.4.1 CETIRIZINE
8.3.4.2 BROMPHENIRAMINE
8.3.4.3 DIPHENHYDRAMINE
8.3.4.4 TERFENADINE
8.3.4.5 TRIMEPRAZINE
8.3.4.6 OTHERS
8.3.5 CORTICOSTEROIDS
8.3.5.1 PREDNISONE
8.3.5.2 PREDNISOLONE
8.3.5.3 DEXAMETHASON
8.3.5.4 OTHERS
8.3.6 ANTIBLOAT
8.3.6.1 DOCUSATE
8.3.6.2 SIMETHICONE
8.3.6.3 OTHERS
8.3.7 HORMONAL
8.3.7.1 EQUINE CHORIONIC GONADOTROPIN
8.3.7.2 CLOPROSTENOL
8.3.7.3 OXYTOCIN
8.3.7.4 OTHERS
8.4 SUPPLEMENTS
8.4.1 VITAMINS
8.4.2 MINERALS
8.4.3 MOLD INHIBITOR
8.4.4 TOXIN BINDER
8.4.5 FEED ACIDIFIERS
8.4.6 OTHERS
9 INDONESIA, MALAYSIA, VIETNAM,THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, & INDIA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE
9.1 OVERVIEW
9.2 FOOD PRODUCTION
9.2.1 POULTRY
9.2.2 CATTLE
9.2.3 SWINE
9.2.4 FISH
9.2.5 OTHERS
9.3 COMPANION ANIMALS
9.3.1 DOGS
9.3.2 CATS
9.3.3 HORSES
9.3.4 OTHERS
10 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA & INDIA VETERINARY MEDICINE MARKET, BY DOSAGE
10.1 OVERVIEW
10.2 SOLID
10.2.1 TABLET
10.2.2 POWDER
10.2.3 OTHERS
10.3 LIQUID
10.3.1 SYRUP
10.3.2 SUSPENSION
10.3.3 SOLUTION
10.3.4 BOLUS
10.3.5 OTHERS
10.4 SEMI-SOLID
10.4.1 GEL
10.4.2 CREAM
10.4.3 OTHERS
11 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA & INDIA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION
11.1 OVERVIEW
11.2 ORAL
11.3 PARENTERAL
11.4 TOPICAL
12 INDONESIA, MALAYSIA, VIETNAM,THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, & INDIA VETERINARY MEDICINE MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 FOOT AND MOUTH DISEASE
12.3 AUTOIMMUNE DISEASES
12.4 BACTERIAL DISEASES
12.5 HELMINTHES INFECTION
12.6 BLUETONGUE
12.7 CANINE ATOPIC DERMATITIS
12.8 OTHERS
13 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA & INDIA VETERINARY MEDICINE MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITALS
13.3 VETERINARY CLINICS
13.4 HOMECARE SETTINGS
13.5 LABORATORIES
14 INDONESIA, MALAYSIA, VIETNAM,THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, & INDIA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 DIRECT TENDER
14.3 RETAIL SALES
14.4 ONLINE PHARMACY
14.5 OTHERS
15 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: INDIA
15.2 COMPANY SHARE ANALYSIS: AUSTRALIA
15.3 COMPANY SHARE ANALYSIS: CHINA
15.4 COMPANY SHARE ANALYSIS: INDONESIA
15.5 COMPANY SHARE ANALYSIS: MALAYSIA
15.6 COMPANY SHARE ANALYSIS: NEW ZEALAND
15.7 COMPANY SHARE ANALYSIS: KOREA
15.8 COMPANY SHARE ANALYSIS: VIETNAM
15.9 COMPANY SHARE ANALYSIS: THAILAND
15.1 COMPANY SHARE ANALYSIS: PHILIPPINES
16 COMPANY PROFILE
16.1 ZOETIS SERVICES LLC
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 PRODUCT PORTFOLIO
16.1.4 RECENT DEVELOPMENTS
16.2 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 PRODUCT PORTFOLIO
16.2.4 RECENT DEVELOPMENT
16.3 VIRBAC.
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 PRODUCT PORTFOLIO
16.3.4 RECENT DEVELOPMENT
16.4 CEVA
16.4.1 COMPANY SNAPSHOT
16.4.2 PRODUCT PORTFOLIO
16.4.3 RECENT DEVELOPMENTS
16.5 DECHRA PHARMACEUTICALS PLC
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 PRODUCT PORTFOLIO
16.5.4 RECENT DEVELOPMENT
16.6 ALIVIRA ANIMAL HEALTH LIMITED
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENT
16.7 BENTOLI
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENT
16.8 BIOGÉNESIS BAGÓ
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 BIOLOGISCHE HEILMITTEL HEEL GMBH
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 ECO ANIMAL HEALTH LTD
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENTS
16.11 HUVEPHARMA
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENT
16.12 INDIAN IMMUNOLOGICALS LTD.
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENTS
16.13 INOVET
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENTS
16.14 JUROX PTY LIMITED.
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 KEMIN INDUSTRIES, INC.
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENT
16.16 MANKIND PHARMA
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENT
16.17 MSD ANIMAL HEALTH
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENTS
16.18 PHIBRO ANIMAL HEALTH CORPORATION.
16.18.1 COMPANY SNAPSHOT
16.18.2 REVENUE ANALYSIS
16.18.3 PRODUCT PORTFOLIO
16.18.4 RECENT DEVELOPMENT
16.19 VALOR CHEMICAL CO., LTD
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENT
16.2 VETOQUINOL
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
16.21 ZOVIX PHARMACEUTICALS.
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
Lista de Tablas
TABLE 1 INDIA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 2 AUSTRALIA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 3 CHINA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 4 INDONESIA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 5 MALAYSIA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 6 NEW ZEALAND VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 7 KOREA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 8 VIETNAM VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 9 THAILAND VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 10 PHILIPPINES VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 11 INDIA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 12 AUSTRALIA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 13 CHINA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 14 INDONESIA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 15 MALAYSIA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 16 NEW ZEALAND VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 17 KOREA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 18 VIETNAM VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 19 THAILAND VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 20 PHILIPPINES VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 21 INDIA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 22 AUSTRALIA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 23 CHINA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 24 INDONESIA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 25 MALAYSIA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 26 NEW ZEALAND MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 27 KOREA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 28 VIETNAM MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 29 THAILAND MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 30 PHILIPPINES MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 31 INDIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 32 AUSTRALIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 33 CHINA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 34 INDONESIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 35 MALAYSIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 36 NEW ZEALAND ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 37 KOREA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 38 VIETNAM ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 39 THAILAND ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 40 PHILIPPINES ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 41 INDIA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 42 AUSTRALIA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 43 CHINA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 44 INDONESIA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 45 MALAYSIA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 46 NEW ZEALAND ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 47 KOREA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 48 VIETNAM ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 49 THAILAND ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 50 PHILIPPINES ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 51 INDIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 52 AUSTRALIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 53 CHINA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 54 INDONESIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 55 MALAYSIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 56 NEW ZEALAND ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 57 KOREA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 58 VIETNAM ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 59 THAILAND ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 60 PHILIPPINES ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 61 INDIA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 62 AUSTRALIA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 63 CHINA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 64 INDONESIA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 65 MALAYSIA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 66 NEW ZEALAND OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 67 KOREA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 68 VIETNAM OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 69 THAILAND OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 70 PHILIPPINES OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 71 INDIA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 72 AUSTRALIA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 73 CHINA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 74 INDONESIA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 75 MALAYSIA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 76 NEW ZEALAND MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 77 KOREA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 78 VIETNAM MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 79 THAILAND MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 80 PHILIPPINES MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 81 INDIA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 82 AUSTRALIA KAPPA AGONIST-MU ANTAGONIST S IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 83 CHINA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 84 INDONESIA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 85 MALAYSIA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 86 NEW ZEALAND KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 87 KOREA KAPPA AGONIST-MU ANTAGONIST S IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 88 VIETNAM KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 89 THAILAND KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 90 PHILIPPINES KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 91 INDIA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 92 AUSTRALIA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 93 CHINA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 94 INDONESIA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 95 MALAYSIA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 96 NEW ZEALAND PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 97 KOREA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 98 VIETNAM PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 99 THAILAND PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 100 PHILIPPINES PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 101 INDIA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 102 AUSTRALIA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 103 CHINA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 104 INDONESIA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 105 MALAYSIA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 106 NEW ZEALAND PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 107 KOREA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 108 VIETNAM PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 109 THAILAND PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 110 PHILIPPINES PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 111 INDIA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 112 AUSTRALIA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 113 CHINA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 114 INDONESIA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 115 MALAYSIA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 116 NEW ZEALAND ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 117 KOREA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 118 VIETNAM ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 119 THAILAND ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 120 PHILIPPINES ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 121 INDIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 122 AUSTRALIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 123 CHINA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 124 INDONESIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 125 MALAYSIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 126 NEW ZEALAND ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 127 KOREA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 128 VIETNAM ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 129 THAILAND ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 130 PHILIPPINES ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 131 INDIA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 132 AUSTRALIA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 133 CHINA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 134 INDONESIA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 135 MALAYSIA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 136 NEW ZEALAND ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 137 KOREA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 138 VIETNAM ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 139 THAILAND ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 140 PHILIPPINES ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 141 INDIA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 142 AUSTRALIA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 143 CHINA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 144 INDONESIA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 145 MALAYSIA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 146 NEW ZEALAND HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 147 KOREA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 148 VIETNAM HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 149 THAILAND HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 150 PHILIPPINES HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 151 INDIA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 152 AUSTRALIA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 153 CHINA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 154 INDONESIA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 155 MALAYSIA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 156 NEW ZEALAND SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 157 KOREA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 158 VIETNAM SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 159 THAILAND SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 160 PHILIPPINES SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 161 INDIA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 162 AUSTRALIA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 163 CHINA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 164 INDONESIA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 165 MALAYSIA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 166 NEW ZEALAND VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 167 KOREA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 168 VIETNAM VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 169 THAILAND VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 170 PHILIPPINES VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 171 INDIA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 172 AUSTRALIA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 173 CHINA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 174 INDONESIA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 175 MALAYSIA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 176 NEW ZEALAND FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 177 KOREA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 178 VIETNAM FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 179 THAILAND FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 180 PHILIPPINES FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 181 INDIA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 182 AUSTRALIA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 183 CHINA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 184 INDONESIA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 185 MALAYSIA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 186 NEW ZEALAND COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 187 KOREA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 188 VIETNAM COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 189 THAILAND COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 190 PHILIPPINES COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 191 INDIA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 192 AUSTRALIA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 193 CHINA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 194 INDONESIA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 195 MALAYSIA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 196 NEW ZEALAND VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 197 KOREA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 198 VIETNAM VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 199 THAILAND VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 200 PHILIPPINES VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 201 INDIA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 202 AUSTRALIA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 203 CHINA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 204 INDONESIA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 205 MALAYSIA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 206 NEW ZEALAND SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 207 KOREA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 208 VIETNAM SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 209 THAILAND SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 210 PHILIPPINES SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 211 INDIA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 212 AUSTRALIA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 213 CHINA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 214 INDONESIA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 215 MALAYSIA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 216 NEW ZEALAND LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 217 KOREA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 218 VIETNAM LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 219 THAILAND LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 220 PHILIPPINES LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 221 INDIA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 222 AUSTRALIA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 223 CHINA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 224 INDONESIA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 225 MALAYSIA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 226 NEW ZEALAND SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 227 KOREA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 228 VIETNAM SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 229 THAILAND SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 230 PHILIPPINES SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 231 INDIA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 232 AUSTRALIA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 233 CHINA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 234 INDONESIA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 235 MALAYSIA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 236 NEW ZEALAND VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 237 KOREA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 238 VIETNAM VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 239 THAILAND VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 240 PHILIPPINES VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 241 INDIA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 242 AUSTRALIA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 243 CHINA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 244 INDONESIA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 245 MALAYSIA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 246 NEW ZEALAND VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 247 KOREA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 248 VIETNAM VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 249 THAILAND VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 250 PHILIPPINES VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 251 INDIA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 252 AUSTRALIA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 253 CHINA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 254 INDONESIA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 255 MALAYSIA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 256 NEW ZEALAND VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 257 KOREA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 258 VIETNAM VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 259 THAILAND VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 260 PHILIPPINES VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 261 INDIA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 262 AUSTRALIA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 263 CHINA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 264 INDONESIA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 265 MALAYSIA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 266 NEW ZEALAND VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 267 KOREA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 268 VIETNAM VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 269 THAILAND VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 270 PHILIPPINES VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
Lista de figuras
FIGURE 1 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: SEGMENTATION
FIGURE 2 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: DATA TRIANGULATION
FIGURE 3 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: DROC ANALYSIS
FIGURE 4 INDIA VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 5 AUSTRALIA VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 6 CHINA VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 7 INDONESIA VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 8 MALAYSIA VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 9 NEW ZEALAND VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 10 KOREA VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 11 VIETNAM VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 12 THAILAND VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 13 PHILIPPINES VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 14 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 15 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 16 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: MARKET END USER COVERAGE GRID
FIGURE 17 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: DBMR MARKET POSITION GRID
FIGURE 18 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: SEGMENTATION
FIGURE 19 RISING PET OWNERSHIP AND HUMANIZATION OF PET IS EXPECTED TO DRIVE THE GROWTH OF THE INDIA VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 20 GROWING PREVALENCE OF ANIMAL DISEASES IS EXPECTED TO DRIVE THE GROWTH OF AUSTRALIA VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 21 ADVANCEMENTS IN VETERINARY MEDICINE AND TECHNOLOGY IS EXPECTED TO DRIVE THE GROWTH OF CHINA VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 22 INCREASING GOVERNMENT INITIATIVES FOR ANIMAL HEALTH AND WELFARE IS EXPECTED TO DRIVE THE GROWTH OF INDONESIA VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 23 RISING PET OWNERSHIP AND HUMANIZATION OF PET IS EXPECTED TO DRIVE THE GROWTH OF MALAYSIA VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 24 GROWING PREVALENCE OF ANIMAL DISEASES IS EXPECTED TO DRIVE THE GROWTH OF NEW ZEALAND VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 25 ADVANCEMENTS IN VETERINARY MEDICINE AND TECHNOLOGY IS EXPECTED TO DRIVE THE GROWTH OF KOREA VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 26 INCREASING GOVERNMENT INITIATIVES FOR ANIMAL HEALTH AND WELFARE IS EXPECTED TO DRIVE THE GROWTH OF VIETNAM VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 27 RISING PET OWNERSHIP AND HUMANIZATION OF PET ARE EXPECTED TO DRIVE THE GROWTH OF THAILAND VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 28 THE GROWING PREVALENCE OF ANIMAL DISEASES IS EXPECTED TO DRIVE THE GROWTH OF PHILIPPINES VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 29 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF INDIA VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 30 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF AUSTRALIA VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 31 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF CHINA VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 32 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF INDONESIA VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 33 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF MALAYSIA VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 34 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF NEW ZEALAND VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 35 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF KOREA VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 36 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF VIETNAM VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 37 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THAILAND VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 38 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF VIETNAM VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 39 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET
FIGURE 40 INDIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2022
FIGURE 41 AUSTRALIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2022
FIGURE 42 CHINA VETERINARY MEDICINE MARKET: BY PRODUCT, 2022
FIGURE 43 INDONESIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2022
FIGURE 44 MALAYSIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2022
FIGURE 45 NEW ZEALAND VETERINARY MEDICINES MARKET: BY PRODUCT, 2022
FIGURE 46 KOREA VETERINARY MEDICINE MARKET: BY PRODUCT, 2022
FIGURE 47 VIETNAM VETERINARY MEDICINE MARKET: BY PRODUCT, 2022
FIGURE 48 THAILAND VETERINARY MEDICINES MARKET: BY PRODUCT, 2022
FIGURE 49 PHILIPPINES VETERINARY MEDICINES MARKET: BY PRODUCT, 2022
FIGURE 50 INDIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 51 AUSTRALIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 52 CHINA VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 53 INDONESIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 54 MALAYSIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 55 NEW ZEALAND VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 56 KOREA VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 57 VIETNAM VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 58 THAILAND VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 59 PHILIPPINES VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 60 INDIA VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 61 AUSTRALIA VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 62 CHINA VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 63 INDONESIA VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 64 MALAYSIA VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 65 NEW ZEALAND VETERINARY MEDICINES MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 66 KOREA VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 67 VIETNAM VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 68 THAILAND VETERINARY MEDICINES MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 69 PHILIPPINES VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 70 INDIA VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 71 AUSTRALIA VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 72 CHINA VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 73 INDONESIA VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 74 MALAYSIA VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 75 NEW ZEALAND VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 76 KOREA VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 77 VIETNAM VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 78 THAILAND VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 79 PHILIPPINES VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 80 INDIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 81 AUSTRALIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 82 CHINA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 83 INDONESIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 84 MALAYSIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 85 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 86 KOREA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 87 VIETNAM VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 88 THAILAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 89 PHILIPPINES VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 90 INDIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 91 AUSTRALIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 92 CHINA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 93 INDONESIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 94 MALAYSIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 95 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 96 KOREA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 97 VIETNAM VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 98 THAILAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 99 PHILIPPINES VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 100 INDIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 101 AUSTRALIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 102 CHINA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 103 INDONESIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 104 MALAYSIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 105 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 106 KOREA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 107 VIETNAM VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 108 THAILAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 109 PHILIPPINES VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 110 INDIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 111 AUSTRALIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 112 CHINA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 113 INDONESIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 114 MALAYSIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 115 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 116 KOREA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 117 VIETNAM VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 118 THAILAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 119 PHILIPPINES VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 120 INDIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 121 AUSTRALIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 122 CHINA VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 123 INDONESIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 124 MALAYSIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 125 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 126 KOREA VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 127 VIETNAM VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 128 THAILAND VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 129 PHILIPPINES VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 130 INDIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 131 AUSTRALIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 132 CHINA VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 133 INDONESIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 134 MALAYSIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 135 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 136 KOREA VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 137 VIETNAM VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 138 THAILAND VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 139 PHILIPPINES VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 140 INDIA VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 141 AUSTRALIA VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 142 CHINA VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 143 INDONESIA IMMUNODIAGNOSTICS SMARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 144 MALAYSIA VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 145 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 146 KOREA VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 147 VIETNAM VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 148 THAILAND VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 149 PHILIPPINES VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 150 INDIA VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 151 AUSTRALIA VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 152 CHINA VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 153 INDONESIA VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 154 MALAYSIA VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 155 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 156 KOREA VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 157 VIETNAM VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 158 THAILAND VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 159 PHILIPPINES VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 160 INDIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 161 AUSTRALIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 162 CHINA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 163 INDONESIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 164 MALAYSIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 165 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 166 KOREA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 167 VIETNAM VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 168 THAILAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 169 PHILIPPINES VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 170 INDIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 171 AUSTRALIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 172 CHINA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 173 INDONESIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 174 MALAYSIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 175 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 176 KOREA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 177 VIETNAM VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 178 THAILAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 179 PHILIPPINES VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 180 INDIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 181 AUSTRALIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 182 CHINA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 183 INDONESIA IMMUNODIAGNOSTICS SMARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 184 MALAYSIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 185 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 186 KOREA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 187 VIETNAM VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 188 THAILAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 189 PHILIPPINES VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 190 INDIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 191 AUSTRALIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 192 CHINA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 193 INDONESIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 194 MALAYSIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 195 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 196 KOREA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 197 VIETNAM VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 198 THAILAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 199 PHILIPPINES VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 200 INDIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 201 AUSTRALIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 202 CHINA VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 203 INDONESIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 204 MALAYSIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 205 NEW ZEALAND VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 206 KOREA VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 207 VIETNAM VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 208 THAILAND VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 209 PHILIPPINES VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 210 INDIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 211 AUSTRALIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 212 CHINA VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 213 INDONESIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 214 MALAYSIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 215 NEW ZEALAND VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 216 KOREA VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 217 VIETNAM VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 218 THAILAND VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 219 PHILIPPINES VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 220 INDIA VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 221 AUSTRALIA VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 222 CHINA VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 223 INDONESIA VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 224 MALAYSIA VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 225 NEW ZEALAND VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 226 KOREA VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 227 VIETNAM VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 228 THAILAND VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 229 PHILIPPINES VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 230 INDIA VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 231 ASUTRALIA VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 232 CHINA VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 233 INDONESIA VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 234 MALAYSIA VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 235 NEW ZEALAND VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 236 KOREA VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 237 VIETNAM VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 238 THAILAND VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 239 PHILIPPINES VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 240 INDIA VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 241 AUSTRALIA VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 242 CHINA VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 243 INDONESIA VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 244 MALAYSIA VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 245 NEW ZEALAND VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 246 KOREA VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 247 VIETNAM VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 248 THAILAND VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 249 PHILIPPINES VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 250 INDIA VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 251 AUSTRALIA VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 252 CHINA VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 253 INDONESIA VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 254 MALAYSIA VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 255 NEW ZEALAND VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 256 KOREA VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 257 VIETNAM VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 258 THAILAND VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 259 PHILIPPINES VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 260 INDIA VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 261 AUSTRALIA VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 262 CHINA VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 263 INDONESIA IMMUNODIAGNOSTICS SMARKET: BY END USER, CAGR (2023-2030)
FIGURE 264 MALAYSIA VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 265 NEW ZEALAND VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 266 KOREA VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 267 VIETNAM VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 268 THAILAND VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 269 PHILIPPINES VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 270 INDIA VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 271 AUSTRALIA VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 272 CHINA VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 273 INDONESIA VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 274 MALAYSIA VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 275 NEW ZEALAND VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 276 KOREA VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 277 VIETNAM VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 278 THAILAND VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 279 PHILIPPINES VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 280 INDIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 281 AUSTRALIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 282 CHINA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 283 INDONESIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 284 MALAYSIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 285 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 286 KOREA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL ,2022
FIGURE 287 VIETNAM VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 288 THAILAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 289 PHILIPPINES VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 290 INDIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 291 AUSTRALIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 292 CHINA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 293 INDONESIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 294 MALAYSIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 295 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 296 KOREA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 297 VIETNAM VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 298 THAILAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 299 PHILIPPINES VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 300 INDIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 301 AUSTRALIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 302 CHINA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 303 INDONESIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 304 MALAYSIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 305 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 306 KOREA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 307 VIETNAM VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 308 THAILAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 309 PHILIPPINES VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 310 INDIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 311 ASUTRALIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 312 CHINA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 313 INDONESIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 314 MALAYSIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 315 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 316 KOREA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 317 VIETNAM VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 318 THAILAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 319 PHILIPPINES VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 320 INDIA VETERINARY MARKET: COMPANY SHARE 2022 (%)
FIGURE 321 AUSTRALIA VETERINARY MARKET: COMPANY SHARE 2022 (%)
FIGURE 322 CHINA VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)
FIGURE 323 INDONESIA VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)
FIGURE 324 MALAYSIA VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)
FIGURE 325 NEW ZEALAND VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)
FIGURE 326 KOREA VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)
FIGURE 327 VIETNAM VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)
FIGURE 328 THAILAND VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)
FIGURE 329 PHILIPPINES VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)
Metodología de investigación
La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.
La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.
Personalización disponible
Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.
